TokenPost·

AstraZeneca Posts $16.21 Billion in Q3 Revenue, Reaffirms 2026 Outlook

Your call?

Revenue rose 7% year over year. The company expects Core EPS to increase by a low double-digit percentage at constant exchange rates.

Share

More news